SR 11237

SR 11237 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

SR 11237 is a pan RXR agonist with without RAR activity. It is used in treatment of neurodegenerative diseases.

Biologische Aktivität

Pan retinoid X receptor (RXR) agonist that is devoid of any RAR activity.

SR 11237 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

SR 11237 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Nantong HI-FUTURE Biology Co., Ltd.	+undefined18051384581	sales@chemhifuture.com	China	3136	58
Aladdin Scientific	+1-833-552-7181	sales@aladdinsci.com	United States	57511	58
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15848	69
Syntechem Co.,Ltd		info@syntechem.com	China	12990	57
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4153	55
EMMX Biotechnology LLC	888-539-0666	info@emmx.com	United States	8449	60
Shanghai Rechem science Co., Ltd.	21-31433387 15618786686	sales@rechemscience.com	China	2995	58
Hangzhou Synstar pharmaceutical Technology CO.,Ltd	0571-85361029	synstar518@163.com	China	1991	58
Taizhou Crene Biotechnology Co. Ltd.	0576-88813233 13396860566	sales@pharm-intermediates.com	China	2013	58

---

• SR 11237
• 4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-benzoicacid
• 4-(2-(5,5,8,8-tetraMethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolan-2-yl)benzoic acid
• BMS 188649
• BMS649
• Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-
• Retinoid X receptors,bone,BMS 649,transactivate,BMS649,Retinoic acid receptors,reporter,ossification,RAR/RXR,inhibit,Inhibitor,RXR/RXR,BMS-649,SR11237,homodimers,gene,SR-11237
• 146670-40-8